Getting a coronary angiogram—a test to see inside your heart's arteries—involves injecting a special dye. For some people, that dye can cause a sudden drop in kidney function, a problem called contrast-induced acute kidney injury (CI-AKI). It's a serious complication that doctors try hard to prevent with simple measures like giving extra fluids.
Researchers in Egypt tested if adding a medication could offer more protection. They studied 120 patients getting an elective angiogram. One group got extra fluids alone, which is standard care. Another got fluids plus a high dose of N-acetylcysteine (NAC), an antioxidant sometimes used for this purpose. A third group got fluids plus a single high dose of atorvastatin, a common cholesterol-lowering drug.
The results showed a difference. In the group that got just fluids, about 33% developed kidney injury. In the NAC group, it was 20%. In the atorvastatin group, it was about 13%. The lower rate with atorvastatin was statistically significant compared to fluids alone. However, when looking at other in-hospital outcomes, like major complications, there was no significant difference between the groups.
It's important to view this as a promising signal, not a definitive answer. This was a single, moderate-sized study focused on Egyptian patients having planned procedures. The researchers did not report on the safety or side effects of giving these high medication doses in this context, or on what happens to patients beyond their hospital stay. More research is needed to see if this benefit holds up in larger, more diverse groups of people.
